Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The nation’s health care system provides unrestricted access to hepatitis C treatment.
A national survey found that primary care physicians had little interest in prescribing buprenorphine or naltrexone.
Even after federal regulators relaxed rules requiring daily clinic visits, these bad actors are still bringing patients in for monitoring.
The coronavirus pandemic has upended the usual systems governing the dispensation of medication-assisted treatment.
Experts are calling for greater flexibility in clinicians’ ability to deliver treatments for opioid use disorder.
One bill would create 1,000 new residency positions for physicians going into addiction treatment medicine.
A systematic review of hep C treatment outcomes in this population shows they have high cure rates and relatively low reinfection rates.
A recent study found that providing opioid use disorder treatment was associated with a high hep C cure rate and less drug use.
Researchers found critical gaps in the scientific knowledge about the opioid epidemic.
The state will provide prisoners medication-assisted treatment to treat opioid use disorder and is creating more syringe services programs.
Researchers followed people with a drug-injection history who had been cured of hepatitis C and were receiving addiction treatment.
The first national study of opioid use disorder recovery found that staying off such drugs often requires great effort and various services.
Researchers used mathematical modeling to analyze the benefits of treating with buprenorphine/naloxone on-site.
The nation has provided unrestricted access to hepatitis C treatment since 2016.
Health care facilities serving people who use drugs are well-positioned to initiate hepatitis C testing. But ’they don’t.
A new meta-analysis finds this population has a high success rate on hepatitis C therapy.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.